PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sodium octyl sulphate | 205-535-5 | 142-31-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Sodium hydrogen glutamate | 205-538-1 | 142-47-2 | - | - | 3 | - | 1 | - | - | - | - | Details |
| N-(1-oxooctadecyl)sarcosine | 205-539-7 | 142-48-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Piperazine dihydrochloride | 205-551-2 | 142-64-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Tetrahydropyran | 205-552-8 | 142-68-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Heptane | 205-563-8 | 142-82-5 | - | - | 1 | - | - | - | - | - | - | Details |
| Dipropylamine | 205-565-9 | 142-84-7 | - | - | 1 | - | - | - | - | - | - | Details |
| Sodium decyl sulphate | 205-568-5 | 142-87-0 | - | - | - | - | 1 | - | - | - | - | Details |
| Piperazine adipate | 205-569-0 | 142-88-1 | - | - | - | - | 1 | - | - | - | - | Details |
| Dodecyl methacrylate | 205-570-6 | 142-90-5 | - | - | 3 | - | 1 | 1 | - | - | - | Details |
| Isopropyl palmitate | 205-571-1 | 142-91-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Hexyl acetate | 205-572-7 | 142-92-7 | - | - | 2 | - | - | - | - | - | - | Details |
| Dibutyl ether | 205-575-3 | 142-96-1 | - | - | 1 | - | - | - | - | - | - | Details |
| Lauric acid | 205-582-1 | 143-07-7 | - | - | 2 | - | - | - | - | - | - | Details |
| Nonan-1-ol | 205-583-7 | 143-08-8 | - | - | 1 | - | - | - | - | - | - | Details |
| 2-(2-(2-butoxyethoxy)ethoxy)ethanol | 205-592-6 | 143-22-6 | - | - | 4 | - | 1 | - | - | - | - | Details |
| Bis(2-(2-methoxyethoxy)ethyl) ether | 205-594-7 | 143-24-8 | - | - | - | - | 1 | 1 | 1 | - | - | Details |
| (Z)-octadec-9-enol | 205-597-3 | 143-28-2 | - | - | 1 | - | - | - | - | - | - | Details |
| Bis(2-(2-butoxyethoxy)ethoxy)methane | 205-598-9 | 143-29-3 | - | - | 4 | - | - | - | - | - | - | Details |
| Sodium cyanide | 205-599-4 | 143-33-9 | - | - | 1 | - | - | - | - | - | - | Details |
| Chlordecone | 205-601-3 | 143-50-0 | - | - | - | - | - | - | - | - | - | Details |
| Tris(2-ethylhexyl) 2-(acetyloxy)propane-1,2,3-tricarboxylate | 205-617-0 | 144-15-0 | - | - | 1 | - | - | - | - | - | - | Details |
| 2,2,4-trimethylpentane-1,3-diol | 205-619-1 | 144-19-4 | - | - | 3 | - | - | - | - | - | - | Details |
| Tripiperazine dicitrate | 205-622-8 | 144-29-6 | - | - | - | - | 1 | - | - | - | - | Details |
|
Methyldithiocarbamic acid
show/hide
|
205-632-2 | 144-54-7 | - | - | - | - | - | 1 | - | - | - | Details |
| Sodium hydrogencarbonate | 205-633-8 | 144-55-8 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Oxalic acid | 205-634-3 | 144-62-7 | - | - | 4 | - | - | - | - | - | - | Details |
| 29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32 copper | 205-685-1 | 147-14-8 | - | - | 1 | - | - | - | - | - | - | Details |
| L-proline | 205-702-2 | 147-85-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Quinolin-8-ol | 205-711-1 | 148-24-3 | - | - | - | - | 1 | 1 | - | - | - | Details |
| Thiabendazole | 205-725-8 | 148-79-8 | - | - | - | - | - | 1 | - | - | - | Details |
| Benzothiazole-2-thiol | 205-736-8 | 149-30-4 | 1 | - | - | - | - | - | - | - | - | Details |
| Sodium hydroxymethanesulphinate | 205-739-4 | 149-44-0 | 1 | - | 5 | - | - | - | - | - | - | Details |
| 2-ethylhexanoic acid | 205-743-6 | 149-57-5 | 1 | - | - | - | 1 | - | - | - | - | Details |
| Dichloro(methyl)(phenyl)silane | 205-746-2 | 149-74-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
| N,N-bis(2-hydroxyethyl)glycine | 205-755-1 | 150-25-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Trisodium hydrogen ethylenediaminetetraacetate | 205-758-8 | 150-38-9 | - | - | 1 | - | 1 | - | - | - | - | Details |
| N-(2-hydroxyethyl)ethylenediaminetriacetic acid | 205-759-3 | 150-39-0 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Alverine | 205-763-5 | 150-59-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Mequinol | 205-769-8 | 150-76-5 | - | - | 3 | - | - | - | - | - | - | Details |
| Citronellyl acetate | 205-775-0 | 150-84-5 | - | - | 1 | - | - | - | - | - | - | Details |
| Disodium succinate | 205-778-7 | 150-90-3 | - | - | - | - | 1 | - | - | - | - | Details |
| α,α-dimethylphenethyl acetate | 205-781-3 | 151-05-3 | - | - | 1 | - | - | - | - | - | - | Details |
| Sodium dodecyl sulphate | 205-788-1 | 151-21-3 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Dodecyl hydrogen sulphate | 205-791-8 | 151-41-7 | - | - | - | - | 1 | - | - | - | - | Details |
| Potassium cyanide | 205-792-3 | 151-50-8 | - | - | 1 | - | - | - | - | - | - | Details |
| Aziridine | 205-793-9 | 151-56-4 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Zinc di(benzothiazol-2-yl) disulphide | 205-840-3 | 155-04-4 | - | - | 3 | - | - | - | - | - | - | Details |
| Levamfetamine | 205-850-8 | 156-34-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Calcium cyanamide | 205-861-8 | 156-62-7 | - | - | 4 | - | 1 | - | - | - | 1 | Details |